NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES. Eur. J. Emerg. Mol. Sci. [Internet]. 2024 Dec. 26 [cited 2026 Jan. 15];1(01):69-7. Available from: https://parthenonfrontiers.com/index.php/ejems/article/view/31